SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-057805
Filing Date
2023-11-02
Accepted
2023-11-02 10:00:31
Documents
94
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mcrb-20230930.htm   iXBRL 10-Q 3411330
2 EX-31.1 mcrb-ex31_1.htm EX-31.1 14719
3 EX-31.2 mcrb-ex31_2.htm EX-31.2 14612
4 EX-32.1 mcrb-ex32_1.htm EX-32.1 8982
5 EX-32.2 mcrb-ex32_2.htm EX-32.2 8950
  Complete submission text file 0000950170-23-057805.txt   11955737

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mcrb-20230930_lab.xml EX-101.LAB 632287
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mcrb-20230930.xsd EX-101.SCH 85760
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mcrb-20230930_cal.xml EX-101.CAL 63892
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mcrb-20230930_pre.xml EX-101.PRE 495861
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mcrb-20230930_def.xml EX-101.DEF 316232
88 EXTRACTED XBRL INSTANCE DOCUMENT mcrb-20230930_htm.xml XML 2010364
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37465 | Film No.: 231370487
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences